Amendment to Share Exchange Agreement, dated September 16, 2020
AMENDMENT NO. 1 TO SHARE EXCHANGE AGREEMENT
THIS AMENDMENT NO. 1 TO SHARE EXCHANGE AGREEMENT (this "Amendment") is made as of September 16, 2020, by and among MedGen, Inc., a Wyoming corporation (the "Parent"), 9430075 Canada Ltd., a company incorporated in Manitoba, Canada (the “Company”), and each of the shareholders of the Company named herein as signatories (the “Shareholders”). Each of the parties to this Agreement is individually referred to herein as a “Party” and collectively as the “Parties.”
WHEREAS, the Company has entered into that certain Share Exchange Agreement, dated as of June 25, 2020, with the Company and its Shareholders (the "Agreement"); and;
WHEREAS, the Parent, the Company and the Shareholders desire to amend the Agreement to increase the number of Parent Shares (as such term is defined in the Agreement) to be acquired by the Shareholders in order to reflect a 70% interest in the Parent, as the Parties have negotiated, following a one for five thousand reverse split of outstanding shares of common stock in Parent.
NOW THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:
1. Amendment of Exhibit A. Exhibit A to the Agreement is hereby amended and restated in its entirety to read as is set forth as Exhibit A to this Amendment.
2. No Other Amendments. Except as amended hereby, the Agreement shall remain in full force and effect.
3. Governing Law. This Amendment shall be governed in all respects by the laws of the State of Nevada without regard to choice of laws or conflict of laws provisions thereof.
4. Counterparts. This Amendment may be executed in any number of counterparts and signatures may be delivered by facsimile, each of which may be executed by less than all Investors, each of which shall be enforceable against the parties actually executing such counterparts, and all of which together shall constitute one instrument.
[SIGNATURE PAGE FOLLOWS]
IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first above written.
The Parent: MEDGEN, INC.
By: /s/ Adir Iakya
Name: Adir Iakya
The Company: 9430075 CANADA LTD.
By: Adir Iakya
Name: Adir Iakya
The Class A Common Voting Shareholders:
/s/ Lisa Lester
/s/ Nicole Harris
|Company Shareholder||Class of Company Stock|| |
Number of Shares of
|Number of Parent Shares to be Exchanged||Number of Parent Common in Conversion||Number of Parent Common After 1 for 5,000 Reverse Split|
|Column “A”||Column “B”||Column “C”||Column “D”||Column “E”||Column “F”|
|Lisa Lester||Class A Common||150||321,429||112,500,000,000||22,500,000|
|Nicole Harris||Class A Common||150||321,428||112,500,000,000||22,500,000|
|Total Class A Common||300|
|Michal Kulaczkowski||Class B Common||50||50,000||17,500,000,000||3,500,000|
|Adam Littas||Class B Common||25||25,000||8,750,000,000||1,750,000|
|Shannon Coughlin||Class B Common||10||10,000||350,000,0000||700,000|
|10004596 Canada Ltd.||Class B Common||25||25,000||8,750,000,000||1,750,000|
|Andrzej Delgado||Class B Common||10||10,000||350,000,0000||700,000|
|Michael Kahiri||Class B Common||212.143||212,143||74,250,000,000||14,850,000|
|Total Class B Common||322.143|
|Gord Schum||Class B Preferred||25,000||25,000||8,750,000,000||1,750,000|
|Total Class B Preferred||25,000|